About 10% of US women of reproductive age
are iron deficient.
Gupta et al. (CDC), American Journal of Clinical Nutrition 2017, NHANES 2007 to 2010; iron deficiency 10.4% in nonpregnant females aged 15 to 49. ↗Research-backed mineral with potential health benefits. Replenishes your body's iron stores. Needed to make hemoglobin, which carries oxygen in your blood.
Reviewed March 2026
Public health figures for this ingredient, reported by the agencies that publish them, cited and dated.
About 10% of US women of reproductive age
are iron deficient.
Gupta et al. (CDC), American Journal of Clinical Nutrition 2017, NHANES 2007 to 2010; iron deficiency 10.4% in nonpregnant females aged 15 to 49. ↗About 20% of US women aged 19 to 30
take in less iron from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 37 (iron), females 19-30: 20% below EAR (SE 1.1). ↗About 19% of US women aged 31 to 50
take in less iron from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 37 (iron), females 31-50: 19% below EAR (SE 1.1). ↗About 17% of US girls aged 14 to 18
take in less iron from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 37 (iron), females 14-18: 17% below EAR (SE 1.7). ↗Fewer than 3% of US men aged 19 and over
take in less iron from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 37 (iron), males 19+: reported as less than 3% below EAR. ↗Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Source: NIH ODS + WHO guidelines
A multicentre placebo-controlled randomised trial in 198 nonanemic menstruating women aged 18 to 53, all with ferritin below 50 ug/L and haemoglobin above 12.0 g/dL, gave 80 mg elemental iron as ferrous sulfate daily for 12 weeks. Fatigue on the Current and Past Psychological Scale fell 47.7% with iron and 28.8% with placebo, a modest between-group difference of 18.9%. At 12 weeks iron raised haemoglobin by 0.32 g/dL and ferritin by 11.4 ug/L against placebo. Biological markers were measured at 6 and 12 weeks. No effect was seen on quality of life, depression or anxiety.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Ferrous Sulfate is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
Outcomes the engine found studied for these actives as a combination, not one at a time. Each is a finding a named trial measured, cited and dated, never written by the brand.
In a controlled radioiron study in 63 men, adding ascorbic acid to a non-heme iron meal increased iron absorption in proportion to the dose, from about 1.6 times the meal alone at 25 mg to about 9 times at 1000 mg.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Fail closed. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Vitamin C reduces supplemental iron to its soluble ferrous form and holds it in a complex that stays dissolved as gut contents turn alkaline, so more iron reaches the absorbing surface of the small intestine. It also offsets absorption blockers such as the phytates in grains and the tannins in tea and coffee.
A large calcium dose taken in the same sitting reduces how much iron the gut takes up, a well-documented interaction, which is why the two minerals are usually spaced a few hours apart rather than swallowed together.
Iron and zinc are both divalent metals that share the DMT1 uptake pathway in the gut lining, so high supplemental doses taken together on an empty stomach compete and each can blunt the other's uptake. Taking them with food or at separate times eases that competition.
Copper-dependent ferroxidases, hephaestin in the gut wall and ceruloplasmin in plasma, oxidise iron so transferrin can carry it. Without copper, absorbed iron does not move into circulation properly.
Vitamin A status supports the release of stored iron from tissues into circulation for red cell formation. Low vitamin A limits how much benefit a given iron intake delivers.
Riboflavin-derived FAD supports the reductase activity that presents iron in its absorbable ferrous state and the mobilisation of iron out of ferritin stores. Riboflavin status changes how much iron is actually used.
Pyridoxal phosphate is the cofactor for ALA synthase, the first and rate-setting step of heme synthesis, which is where iron gets incorporated. Iron with no heme ring to enter cannot be used.
Red cell formation needs iron for heme and B12 for the DNA synthesis of the dividing precursor cells. Short supply of one caps the response to the other.
Folate supplies the one-carbon units for the DNA synthesis that lets red cell precursors divide, while iron fills the heme they carry. Both are required for normal red blood cell formation.
Manganese and ferrous iron are both carried across the intestinal brush border by DMT1, so a large dose of one reduces uptake of the other. Separate them across the day.
Catechins bind non-heme iron in the gut lumen into complexes that are not absorbed. This is one of the largest single inhibitors of iron uptake from a meal.
Proanthocyanidins from grape seed bind non-heme iron in the lumen and hold it in a form the transporter cannot take up. Dosing them together lowers the iron actually absorbed.
Curcumin is an iron chelator and binds iron in the gut and in tissue, lowering the amount available for absorption. The interaction runs in the direction of less iron uptake.
Quercetin's catechol groups chelate ferrous and ferric iron, forming complexes that are poorly absorbed. Taking them in the same dose lowers iron uptake.
Viscous fibre traps minerals in a gel and slows their release at the absorptive surface. Spacing iron away from a large fibre dose keeps uptake predictable.
Phytate binds iron tightly and is the main inhibitor of non-heme iron uptake from plant meals, and phytase hydrolyses it and releases that bound iron. Adding the enzyme raises how much of the same iron dose is absorbable.
Unbound ferrous iron drives the oxidation of membrane fats through Fenton chemistry, and vitamin E is the chain-breaking antioxidant that intercepts that oxidation inside membranes. Pairing them addresses a known consequence of high-dose ferrous salts.
Lactoferrin delivers iron bound in a protein and is absorbed by a receptor route distinct from the DMT1 route ferrous salts use. Comparative studies have run the two head to head as alternative iron sources rather than as a stack, so pairing them is an either-or decision more than an additive one. Where both are present, the total iron load, not a synergy, is what changes.
Iron bisglycinate is a chelated iron form used as an alternative to a simple ferrous salt, and the two have been compared directly over a 12-week supplementation period. Taking both stacks elemental iron from two sources into the same absorption ceiling. Formulators pick one and dose it, rather than combining them for effect.
Tannins bind non-haem iron in the gut lumen and form complexes that are poorly absorbed. Tea, coffee and tannin-rich extracts taken with a ferrous salt lower the fraction absorbed, which is why the usual handling is to separate them by an hour or two. This is textbook absorption chemistry and needs no combination trial.
Divalent metal transporter 1 carries several divalent cations, so a large simultaneous magnesium dose can compete with ferrous iron at the same uptake step. The interaction is dose- and timing-dependent rather than absolute. Separating the two across the day is the practical response.
Ferrous iron stays soluble in an acidic stomach and precipitates as pH rises. Bicarbonate and other alkalinising agents raise gastric pH and reduce the soluble iron fraction available for uptake. This is a known reason to separate iron from antacid-type ingredients.
Lowering gastric pH keeps iron in the more soluble ferrous state and slows its oxidation to the poorly absorbed ferric form. Betaine hydrochloride is used in formulas for exactly that acidifying effect. The size of the benefit depends on baseline gastric acidity, which varies widely between people.
Calcium carbonate both competes with iron at shared uptake steps and neutralises gastric acid, so it works against iron absorption in two ways at once. A calcium supplement and an iron supplement taken together absorb less iron than the iron taken alone. Standard practice is to dose them at different times of day.
Viscous soluble fibres slow gastric emptying and trap minerals in a gel phase, reducing the fraction of a mineral dose that reaches the absorptive surface in a usable form. Guar gum behaves this way with iron as it does with other divalent minerals. The effect is about timing and viscosity, not chemical destruction of the iron.
Fermentation of inulin lowers colonic pH and generates short-chain fatty acids, and both are proposed to support mineral solubility and colonic uptake. Most of the direct evidence concerns calcium and magnesium, with iron less consistently studied. The mechanism is credible; the human iron data are the weaker part.
Galactooligosaccharides are fermented in the proximal colon and have been paired with iron salts in fortification research on the reasoning that lower luminal pH keeps iron soluble. The pairing also aims at the gut microbial shift that follows unabsorbed iron. Evidence here is developing rather than settled.
Coffee and tea reduce non-haem iron absorption, an effect attributed mainly to chlorogenic acids and polyphenols in the beverage rather than to caffeine itself. A caffeine-containing extract that carries those polyphenols will show the effect; isolated caffeine anhydrous is a much weaker case. Stated precisely because the common shorthand credits the wrong molecule.
Activated charcoal adsorbs a broad range of co-ingested substances in the gut lumen. An iron dose taken alongside it is expected to be partly bound and unavailable. Separating doses by several hours is the ordinary handling.
Alpha-lipoic acid and its reduced form chelate transition metals including iron, which is one route by which it lowers metal-catalysed radical formation in laboratory systems. Taken with an iron salt, chelation before absorption is the plausible interaction. Whether that matters at supplement doses in people has not been measured.
Thiol compounds can reduce ferric iron back to the ferrous state and also chelate iron, so the direction of the interaction depends on the local redox environment. In the gut lumen the reducing effect could favour solubility; in tissue, free iron plus a thiol is a redox-active pair. This is a modulating relationship with two directions, not a simple boost.
Glutathione is the main intracellular thiol buffer and constrains what free iron can do redox-chemically inside cells. Unabsorbed or loosely bound iron drives Fenton chemistry that glutathione-dependent enzymes then have to handle. The relationship is a defensive one rather than an absorption boost.
Casein phosphopeptides bind divalent minerals, and dairy protein taken with an iron salt lowers the absorbed fraction. The same phosphopeptides are marketed as calcium-absorption aids, which is the same binding chemistry pointed at a different mineral. Take iron away from a dairy protein serving if absorption is the priority.
Iron that is not absorbed reaches the colon, where it changes the growth balance between resident groups and is one proposed reason oral iron is often poorly tolerated. Certain Lactobacillus strains produce reductases and organic acids that alter luminal iron chemistry. The direction of the net effect in people is still being worked out.
Nothing specific on file for Ferrous Sulfate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.Ferrous sulfate dissociates in gastric acid to free ferrous ion, which is taken up across the duodenal brush border by divalent metal transporter 1.
Ferrous iron oxidises to ferric iron as pH rises; ferric iron is far less soluble at intestinal pH, which is why an acidic stomach and a reducing agent such as ascorbate favour absorption.
Ferrous sulfate heptahydrate is about 20 percent elemental iron by weight, so 325 mg of the salt supplies roughly 65 mg of elemental iron; label figures must state which of the two is meant.
Absorbed iron leaves the enterocyte through ferroportin and is oxidised by hephaestin before binding transferrin for transport in plasma.
It is a straightforward industrial chemical, not something extracted from a plant or an animal. Iron is dissolved in sulfuric acid, and the resulting salt is crystallised out and washed until it is clean enough for supplements. Some of the world's supply is recovered from other industrial processes, which is why the purity grade on the certificate matters more here than the sourcing story.
From a mineral source, then refined and usually bound to a carrier so the body can take it up.
Two routes dominate. One reacts iron metal, scrap or iron oxide with sulfuric acid. The other recovers ferrous sulfate as a co-product, principally from the sulfate-route titanium dioxide process and from steel pickling liquor.
Fe plus H2SO4 gives FeSO4 in solution with hydrogen gas released. Temperature and acid strength govern reaction rate and the impurity profile carried forward.
The liquor is filtered and cooled so ferrous sulfate heptahydrate crystallises out. Repeated crystallisation and washing remove heavy metals and residual acid; co-product streams need more of this work than a metal-plus-acid route.
Pharmaceutical and food grades are specified on assay, on heavy metals such as lead, arsenic, cadmium and mercury, and on ferric iron content. Technical-grade material from the same reaction is not interchangeable with a USP grade.
Heptahydrate is dried under controlled heat and humidity to approach the monohydrate, raising elemental iron per gram. Overdrying oxidises the surface to ferric sulfate.
Milled to a defined particle size, sometimes coated or granulated to limit oxidation and improve tablet flow, then packed with desiccant under low humidity.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Ferrous Sulfate is the sulfate form of Iron. Same mineral, bound to a different partner, so absorption and feel differ from form to form.
These are the studies our verdict leans on, chosen from the 4,236 we read for Ferrous Sulfate. The full linked list is below.
6 sources behind our Ferrous Sulfate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 121,340 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Ferrous Sulfate is, not how risky it is. A report is not proof Ferrous Sulfate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.